Evidence map›Paper›PMID 32215001›Full record

ReviewScience China. Chemistry2013

Multiple biological functions and pharmacological effects of lycorine.

ZhiFei Cao, Ping Yang, QuanSheng Zhou

Open access · bronzeAbstract readReview
In one paragraph

Review in Science China. Chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Cancers · 2025
    Article
  11. Article
  12. CD14Frontiers in cellular and infection microbiology · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Synthetic Approaches to α-, β-, γ-, and δ-lycoranes.European journal of organic chemistry · 2023
    Article
  19. Design of semisynthetic derivatives of the Amaryllidaceae alkaloid ambelline and exploration of theirSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  20. ERK Inhibition Promotes Engraftment of Allografts by Reprogramming T-Cell Metabolism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

ZhiFei CaoCyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, Soochow University, Suzhou, 215006 China.
Ping YangCyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, Soochow University, Suzhou, 215006 China.
QuanSheng ZhouCyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, Soochow University, Suzhou, 215006 China.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lycorine is the major active component from the amaryllidaceae family plant

Indexed as

angiogenesisanti-canceranti-viruslycorineneovascularizationtraditional Chinese medicinal herbs

Identifiers

PMID32215001
PMCPMC7088923
OpenAlexW2253934052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.